Do you want to read an article? Please log in or register.
Evaluating lung cancer risk factors in adults with interstitial lung disease
Lung, Respiratory and Thoracic Cancer
Related content
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Patterns and preoperative risk factors of occult lymph node metastasis in clinical stage I lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Yang YH, Kim HE, Park BJ, Lee JG, Kim DJ, Lee CY
doi: 10.1016/j.lungcan.2025.108461
Lung, Respiratory and Thoracic Cancer
Prevalence and prognostic significance of interstitial lung abnormalities in lung cancer: A meta-analysis
Lung Cancer
Yang R, Wang H, Liu D, Li W
doi: 10.1016/j.lungcan.2025.108458
Lung, Respiratory and Thoracic Cancer
Factors Associated with Disease Progression after Discontinuation of Immune Checkpoint Inhibitors for Immune-Related Toxicity in Patients with Advanced Non-Small Cell Lung Cancer
Clin Cancer Res
Pecci F, Thummalapalli R, Alden SL, Ricciuti B, Alessi JV, Elkrief A, Rizvi H, Wang X, Jeng M, Egger JV, Vaz VR, Barrichello A, Lamberti G, Di Federico A, Santo V, Rossato de Almeida G, Gandhi M, Clark P, Nishino M, Johnson BE, Hellmann M, Schoenfeld AJ, Awad MM
doi: 10.1158/1078-0432.CCR-24-2990
Lung, Respiratory and Thoracic Cancer
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor (R) Classification for Lung Cancer. Results from an International Survey among Pathologists and Thoracic Surgeons
J Thorac Oncol
Hoffmann H, Nicholson AG, Detterbeck FC, Tsao MS, Ostrowski M, Rami-Porta R, Borczuk A, Marino M, Travis WD, Van Schil PE, Edwards J, Members of the R-Subcommittee, and Members of the IASLC Staging and Prognostic Factors Committee and of the Advisory Boards
doi: 10.1016/j.jtho.2024.12.007
CHICAGO 2025
Breast Cancer
T-DXd rechallenge after grade 1 interstitial lung disease appears safe and clinically beneficial in a real-world setting
Further Publications
Antibody-drug conjugate components in association with the incidence of ADC-related interstitial lung disease: A systematic review and meta-analysis
Lung Cancer
Shao T, Yang J, Chen J, Zhang Y, Shou L
doi: 10.1016/j.lungcan.2025.108559
Lung, Respiratory and Thoracic Cancer
Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes
Lung Cancer
Chen R, Donlon TA, Morris BJ, Allsopp RC, Willcox BJ, Masaki KH
doi: 10.1016/j.lungcan.2024.107971
Lung, Respiratory and Thoracic Cancer
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies
Lung Cancer
Akamatsu H, Nishikawa T, Takeda Y, Misumi T, Aoki T, Shoda H, Yamashita M, Sakakura N, Daga H, Sugawara S, Okishio K, Kenmotsu H, Yamamoto N, Tada H, Tsuboi M, Mitsudomi T
doi: 10.1016/j.lungcan.2025.108437
Genitourinary Cancer
Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort
Cancer Epidemiol Biomarkers Prev
Liss MA, Zeltser N, Zheng Y, Lopez C, Liu M, Patel Y, Yamaguchi TN, Eng SE, Tian M, Semmes OJ, Lin DW, Brooks JD, Wei JT, Klein EA, Tewari AK, Mosquera JM, Khani F, Robinson BD, Asad M, Troyer DA, Kagan J, Sanda MG, Thompson IM, Boutros PC, Leach RJ
doi: 10.1158/1055-9965.EPI-24-0326